UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000020490
Receipt number R000023659
Scientific Title Effects of anti-allergic ophthalmic solutions on chemical mediators in tear fluid and on expression of chemical mediator receptors on conjunctival epithelial cells in patients with allergic conjunctivitis
Date of disclosure of the study information 2016/01/15
Last modified on 2017/03/29 05:54:52

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Effects of anti-allergic ophthalmic solutions on chemical mediators in tear fluid and on expression of chemical mediator receptors on conjunctival epithelial cells in patients with allergic conjunctivitis

Acronym

Effects of anti-allergic ophthalmic solutions on chemical mediators in tear fluid and on expression of chemical mediator receptors on conjunctival epithelial cells in patients with allergic conjunctivitis

Scientific Title

Effects of anti-allergic ophthalmic solutions on chemical mediators in tear fluid and on expression of chemical mediator receptors on conjunctival epithelial cells in patients with allergic conjunctivitis

Scientific Title:Acronym

Effects of anti-allergic ophthalmic solutions on chemical mediators in tear fluid and on expression of chemical mediator receptors on conjunctival epithelial cells in patients with allergic conjunctivitis

Region

Japan


Condition

Condition

Allergic conjunctivitis

Classification by specialty

Ophthalmology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To explore changes in tear level of chemical mediators and expression of chemical mediator receptors on conjunctival epithelial cells in patient with allergic conjunctivitis for pre-seasonal therapy with anti-allergic ophthalmic solution

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1

Exploratory

Trial characteristics_2

Pragmatic

Developmental phase

Not applicable


Assessment

Primary outcomes

Expression levels and change in values after 4weeks and 12weeks therapy of chemical mediator receptors on conjunctival epithelial cells

Key secondary outcomes

After 4weeks and 12weeks therapy measured values and change in values of the following
Subjective symptom scores
Objective finding scores
Tear levels of chemical mediators


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Open -no one is blinded

Control

Active

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

3

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

Epinastine ophthalmic solution, apply 1 drop a time, 4 times daily, for 12 weeks

Interventions/Control_2

Olopatadine ophthalmic solution, apply 1 drop a time, 4 times daily, for 12 weeks

Interventions/Control_3

Artificial tear, apply 2-3 drops a time, 5-6 times daily, for 4 weeks and Epinastine ophthalmic solution, apply 1 drop a time, 4 times daily, for 8 weeks

Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Patients who has a positive result of type I allergy test by immuno-cap rapid.

Key exclusion criteria

1.Females who are or may be pregnant, or lactating
2.Patients with a history of hypersensitivity to study drug or test material
3.Patient who the investigator considers ineligible for enrolment

Target sample size

30


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Toru Nakazawa

Organization

Tohoku University Graduate School of Medicine

Division name

Ophthalmology

Zip code


Address

1-1, Seiryo-cho Aobaku, Sendai city, Miyagi

TEL

022-717-7000

Email

ntoru@oph.med.tohoku.ac.jp


Public contact

Name of contact person

1st name
Middle name
Last name Kazuichi Maruyama

Organization

Tohoku University Graduate School of Medicine

Division name

Ophthalmology

Zip code


Address

1-1, Seiryo-cho Aobaku, Sendai city, Miyagi

TEL

022-717-7000

Homepage URL


Email

maruyama-k@oph.med.tohoku.ac.jp


Sponsor or person

Institute

Tohoku University Graduate School of Medicine

Institute

Department

Personal name



Funding Source

Organization

Santen Pharmaceutical Co., Ltd.

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2016 Year 01 Month 15 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2015 Year 11 Month 04 Day

Date of IRB


Anticipated trial start date

2016 Year 02 Month 01 Day

Last follow-up date

2016 Year 12 Month 31 Day

Date of closure to data entry

2016 Year 12 Month 31 Day

Date trial data considered complete

2016 Year 12 Month 31 Day

Date analysis concluded

2017 Year 03 Month 31 Day


Other

Other related information



Management information

Registered date

2016 Year 01 Month 07 Day

Last modified on

2017 Year 03 Month 29 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000023659


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name